Abstract
Introduction In patients with hypertension (HTN) and diabetes mellitus (DM), lifestyles should be optimal to avoid long-term complications. However, it is sometimes unclear whether the disease duration factor could contribute to their improvement.
Objective 1) To analyze the trend of lifestyles in patients with DM or HTN; 2) to determine the association of lifestyles according to the time since diagnosis in these patients.
Materials and methods Analytical cross-sectional study based on Peru’s Demographic and Family Health Survey between 2014 and 2023. Lifestyles were: smoking status, alcohol consumption, and fruit/vegetable consumption. The time since diagnosis variable was dichotomized (< 2 years versus ≥ 2 years).
Results Lifestyle trends between the established years showed a fluctuating pattern, with a significant interruption in 2020, followed by a return to pre-2020 variations, except for a decrease in smokers in subjects with HTN. On the other hand, no significant association was found between any of the three lifestyles and the time since diagnosis of HTN or DM2.
Conclusion The trends found in lifestyles have not resulted in a sustained decrease in bad habits or a constant improvement in healthy lifestyles, except for smokers in patients with HTN, but rather a general state without substantial changes has been maintained. In turn, the disease duration does not seem to be a determining factor for changes in the lifestyles of patients with DM or HTN.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is self-financed.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Joan A. Loayza-Castro, loayzacastrojoan{at}gmail.com
Luisa Erika Milagros Vásquez Romero, erikavr1995{at}gmail.com
Fiorella E. Zuzunaga-Montoya, fiorellazuzunaga{at}gmail.com
Jhonatan Roberto Astucuri Hidalgo, Jhonatanrah{at}gmail.com
Lupita Ana Maria Valladolid-Sandoval, luamavasa1911{at}gmail.com
↵* Víctor Juan Vera-Ponce, vicvepo{at}gmail.com
Data Availability
The data supporting the findings of this study can be accessed by the original research paper at the follow link: https://proyectos.inei.gob.pe/microdatos/